GOEDDEL DAVID V

Director at TULARIK INC · on record since Mar 18, 2004
Chief Executive Officer at TULARIK INC · on record since Mar 18, 2004
10% owner at IMMUNE DESIGN CORP. · on record since Jul 31, 2014
10% owner at Nurix Therapeutics, Inc. · on record since May 7, 2021
10% owner at Arcus Biosciences, Inc. · on record since Mar 19, 2018
Managing Partner at Gritstone bio, Inc. · on record since Sep 27, 2018
10% owner at CONSTELLATION PHARMACEUTICALS INC · on record since Jul 23, 2018
Director at NGM BIOPHARMACEUTICALS INC · on record since Jun 26, 2019
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Jun 26, 2019
Director at Nurix Therapeutics, Inc. · on record since Jul 29, 2020
Director at Tenaya Therapeutics, Inc. · on record since Jul 29, 2021
10% owner at Tenaya Therapeutics, Inc. · on record since Jul 29, 2021
10% owner at Revolution Medicines, Inc. · on record since Nov 18, 2020
10% owner at eFFECTOR Therapeutics, Inc. · on record since Sep 7, 2021
10% owner at Oric Pharmaceuticals, Inc. · on record since Nov 16, 2021
Director at RAPT Therapeutics, Inc. · on record since Oct 30, 2019
10% owner at RAPT Therapeutics, Inc. · on record since Oct 30, 2019

Insider trading activity of GOEDDEL DAVID V

Transactions on record: 226; since Mar 18, 2004

Open-market buys: 145; $176.7M

Open-market sells: 0

Companies traded: 7; last filing May 30, 2025

Figures computed from official regulatory filings — .

Companies where GOEDDEL DAVID V has traded

22 tx · $64.6M · May 30, 2025
161 tx · $87.9M · Apr 8, 2024
2 tx · $936.9K · Mar 23, 2020
13 tx · $7.5M · Nov 4, 2019
3 tx · Oct 2, 2018
12 tx · $15.8M · Oct 30, 2017
13 tx · $1.7M · Aug 17, 2004

Track record of GOEDDEL DAVID V

Statistical track record

Free account

Open-market buys: 147

Last buy: Mar 5, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of GOEDDEL DAVID V

Co-insiders of GOEDDEL DAVID V

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Tenaya Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	107,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Tenaya Therapeutics, Inc.Listing on record	Mar 7, 2025	BuyD (derivative)	35,714,284	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Tenaya Therapeutics, Inc.Listing on record	Mar 7, 2025	BuyD (derivative)	17,857,142	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Tenaya Therapeutics, Inc.Listing on record	Mar 7, 2025	Buy	35,714,284	0.70 USD	$25M	conv 86Unusual sizeFirst in 12mo	SEC
Tenaya Therapeutics, Inc.Listing on record	Oct 21, 2024	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-858,035	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-11,103,333	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-100,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	1,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-90,442	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-16,806	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-24,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-190,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-949,862	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-78,407	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-1,298,908	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-19,619	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-1,298,908	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-2,650,177	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-100,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-134,180	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-24,222	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-968,990	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-2,265,758	—	n/a (No price was disclosed in the filing)		SEC
Tenaya Therapeutics, Inc.Listing on record	Feb 14, 2024	Buy	2,222,222	4.50 USD	$10M	conv 38	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Tenaya Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	107,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Tenaya Therapeutics, Inc.Listing on record	Mar 7, 2025	BuyD (derivative)	35,714,284	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Tenaya Therapeutics, Inc.Listing on record	Mar 7, 2025	BuyD (derivative)	17,857,142	—	n/a (No price was disclosed in the filing)	First in 12mo	SEC
Tenaya Therapeutics, Inc.Listing on record	Mar 7, 2025	Buy	35,714,284	0.70 USD	$25M	conv 86Unusual sizeFirst in 12mo	SEC
Tenaya Therapeutics, Inc.Listing on record	Oct 21, 2024	AwardD (derivative)	34,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-858,035	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-11,103,333	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-100,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	1,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-90,442	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-16,806	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-24,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-190,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-949,862	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-78,407	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-1,298,908	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-19,619	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-1,298,908	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-2,650,177	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-100,000	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-134,180	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	OtherD (derivative)	-24,222	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-968,990	—	n/a (No price was disclosed in the filing)		SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Apr 8, 2024	Other	-2,265,758	—	n/a (No price was disclosed in the filing)		SEC
Tenaya Therapeutics, Inc.Listing on record	Feb 14, 2024	Buy	2,222,222	4.50 USD	$10M	conv 38	SEC